Cited by 524Influenza Virus Research StudiesRespiratory Support and MechanismsRespiratory viral infections research

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.

Influenza virus-related critical illness: pathophysiology and epidemiology

Open access

Kalil, Andre C., Thomas, Paul G.·2019·Critical Care

DOI 10.1186/s13054-019-2539-xPMC PMC6642581

Open this paper in CoChat — free account Open PDF

Abstract

Influenza virus affects the respiratory tract by direct viral infection or by damage from the immune system response. In humans, the respiratory epithelium is the only site where the hemagglutinin (HA) molecule is effectively cleaved, generating infectious virus particles. Virus transmission occurs through a susceptible individual's contact with aerosols or respiratory fomites from an infected individual. The inability of the lung to perform its primary function of gas exchange can result from multiple mechanisms, including obstruction of the airways, loss of alveolar structure, loss of lung epithelial integrity from direct epithelial cell killing, and degradation of the critical extracellular matrix.Approximately 30-40% of hospitalized patients with laboratory-confirmed influenza are diagnosed with acute pneumonia. These patients who develop pneumonia are more likely to be < 5 years old, > 65 years old, Caucasian, and nursing home residents; have chronic lung or heart disease and history of smoking, and are immunocompromised.Influenza can primarily cause severe pneumonia, but it can also present in conjunction with or be followed by a secondary bacterial infection, most commonly by Staphylococcus aureus and Streptococcus pneumoniae. Influenza is associated with a high predisposition to bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial pneumonia are now known to occur with a frequency of 30-50% in both adult and pediatric populations. The H3N2 subtype has been associated with unprecedented high levels of intensive care unit (ICU) admission.Influenza A is the predominant viral etiology of acute respiratory distress syndrome (ARDS) in adults. Risk factors independently associated with ARDS are age between 36 and 55 years old, pregnancy, and obesity, while protective factors are female sex, influenza vaccination, and infections with Influenza A (H3N2) or Influenza B viruses.In the ICU, particularly during the winter season, influenza should be suspected not only in patients with typical symptoms and epidemiology, but also in patients with severe pneumonia, ARDS, sepsis with or without bacterial co-infection, as well as in patients with encephalitis, myocarditis, and rhabdomyolysis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13054-019-2539-x

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
Kwong, J. C., Schwartz, K. L., Campitelli, M. A., Chung, H., Crowcroft, N. S., Karnauchow, T., Katz, K. C., Ko, D. T., McGeer, A., McNally, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1702090 · Cited by 1,231
The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA
Allen, I. C., Scull, M. A., Moore, C. B., Holl, E. K., McElvania-TeKippe, E., Taxman, D. J., Guthrie, E. H., Pickles, R. J., & Ting, J. P.-Y. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.005 · Cited by 1,113
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza (2010) · New England Journal of Medicine · doi:10.1056/nejmra1000449 · Cited by 1,056
Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California
Louie, J. K. (2009) · JAMA · doi:10.1001/jama.2009.1583 · Cited by 1,020
Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis
Narasaraju, T., Yang, E., Samy, R. P., Ng, H. H., Poh, W. P., Liew, A.-A., Phoon, M. C., van Rooijen, N., & Chow, V. T. K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.013 · Cited by 918
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?
Cheung, C., Poon, L., Lau, A., Luk, W., Lau, Y., Shortridge, K., Gordon, S., Guan, Y., & Peiris, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11772-7 · Cited by 889
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy866 · Cited by 844
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840

Show all 89 references

Sorted by citations

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C., Aliano, J. L., & Bhattoa, H. P. (2020) · Nutrients · doi:10.3390/nu12040988 · Cited by 2,128
Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?
Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J. (2019) · Viruses · doi:10.3390/v12010014 · Cited by 1,048
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Verweij, P. E., Rijnders, B. J. A., Brüggemann, R. J. M., Azoulay, É., Bassetti, M., Blot, S. I., Calandra, T., Clancy, C. J., Cornely, O. A., Chiller, T. M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06091-6 · Cited by 465
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A. A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P. A., Krause, R., Cornely, O. A., Perlin, D. S., Lass‐Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 429
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Maftei, N.-M., Raileanu, C. R., Balta, A. A., Ambrose, L., Boev, M., Marin, D. B., & Lisa, E. L. (2024) · Microorganisms · doi:10.3390/microorganisms12020234 · Cited by 381
Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey
Beovič, B., Doušak, M., Ferreira‐Coimbra, J., Nadrah, K., Rubulotta, F. M., Belliato, M., Berger‐Estilita, J., Ayoade, F., Rello, J., & Erdem, H. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa326 · Cited by 271
Mucosal immune response in biology, disease prevention and treatment
Zhou, X., Wu, Y., Zhu, Z., Lu, C., Zhang, C., Zeng, L., Xie, F., Zhang, L., & Zhou, F. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02043-4 · Cited by 230
Viral Infections, the Microbiome, and Probiotics
Harper, A., Vijayakumar, V., Ouwehand, A. C., ter Haar, J., Obis, D., Espadaler, J., Binda, S., Desiraju, S., & Day, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.596166 · Cited by 177
Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip
Bai, H., Si, L., Jiang, A., Belgur, C., Zhai, Y., Plebani, R., Oh, C. Y., Rodas, M., Patil, A., Nurani, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29562-4 · Cited by 171
Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned
Ryabkova, V. A., Churilov, L. P., & Shoenfeld, Y. (2021) · Clinical Immunology · doi:10.1016/j.clim.2020.108652 · Cited by 164
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
Drake, T. M., Riad, A., Fairfield, C. J., Egan, C., Knight, S. R., Pius, R., Hardwick, H., Norman, L., Shaw, C. A., McLean, K. A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00799-6 · Cited by 160
Therapeutic potential of resveratrol against emerging respiratory viral infections
Filardo, S., Pietro, M. D., Mastromarino, P., & Sessa, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107613 · Cited by 158
The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia
Liu, Z., & Ying, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00479 · Cited by 156
Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup
Xu, H., Sheng, S., Luo, W., Xu, X.-F., & Zhang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1277161 · Cited by 157
Necroptosis blockade prevents lung injury in severe influenza
Gautam, A., Boyd, D. F., Nikhar, S., Zhang, T., Siokas, I., de Velde, L.-A. V., Gaevert, J. A., Meliopoulos, V., Thapa, B., Rodríguez, D. A., et al. (2024) · Nature · doi:10.1038/s41586-024-07265-8 · Cited by 131
Self-citation
Comparison of COVID-19 and influenza characteristics
Bai, Y., & Tao, X. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000479 · Cited by 100
From virus to inflammation, how influenza promotes lung damage
Klomp, M., Ghosh, S., Mohammed, S., & Khan, M. N. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ru0820-232r · Cited by 95
Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling
Kim, S. K., Kim, Y. H., Park, S., & Cho, S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.002 · Cited by 96
Oxidative Stress‐Related Mechanisms in SARS‐CoV‐2 Infections
Wieczfińska, J., Kleniewska, P., & Pawliczak, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5589089 · Cited by 91
Influenza Virus Infection Impairs the Gut’s Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids
Sencio, V., Gallerand, A., Machado, M. G., Deruyter, L., Heumel, S., Soulard, D., Barthelemy, J., Cuinat, C., Vieira, A. T., Barthélémy, A., et al. (2021) · Infection and Immunity · doi:10.1128/iai.00734-20 · Cited by 87
Airway tight junctions as targets of viral infections
Linfield, D. T., Raduka, A., Aghapour, M., & Rezaee, F. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1883965 · Cited by 84
Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms
Han, Q., Wen, X., Wang, L., Han, X., Shen, Y., Cao, J. P., Peng, Q., Xu, J., Zhao, L., He, J., et al. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23191 · Cited by 78
Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection
Gopal, R., Marinelli, M. A., & Alcorn, J. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570681 · Cited by 77
Avian Influenza Virus Tropism in Humans
Bakar, U. A., Amrani, L., Kamarulzaman, F., Karsani, S. A., Hassandarvish, P., & Khairat, J. E. (2023) · Viruses · doi:10.3390/v15040833 · Cited by 80
Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
Lamoth, F., Lewis, R. E., Walsh, T. J., & Kontoyiannis, D. P. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab163 · Cited by 74
Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia
Land, W. G. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00140-w · Cited by 77
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
Stubbs, B. J., Koutnik, A. P., Goldberg, E. L., Upadhyay, V., Turnbaugh, P. J., Verdin, E., & Newman, J. C. (2020) · Med · doi:10.1016/j.medj.2020.06.008 · Cited by 71
Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics
Rezkalla, S. H., & Kloner, R. A. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.12.007 · Cited by 69
Recruited atypical Ly6G + macrophages license alveolar regeneration after lung injury
Ruscitti, C., Abinet, J., Maréchal, P., Meunier, M., meeûs, C. D., Vanneste, D., Janssen, P., Dourcy, M., Thiry, M., Bureau, F., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.ado1227 · Cited by 63
Electrochemical Biosensors for the Detection of SARS-CoV-2 and Other Viruses
Imran, S., Ahmadi, S., & Kerman, K. (2021) · Micromachines · doi:10.3390/mi12020174 · Cited by 62
Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury
Li, X., Berg, N. K., Mills, T., Zhang, K., Eltzschig, H. K., & Yuan, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604944 · Cited by 59
Defining the balance between optimal immunity and immunopathology in influenza virus infection
Nguyen, T. H. O., Rowntree, L. C., Chua, B. Y. L., Thwaites, R. S., & Kedzierska, K. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01029-1 · Cited by 61
Regulation of Host Immune Responses against Influenza A Virus Infection by Mitogen-Activated Protein Kinases (MAPKs)
Yu, J., Sun, X., Goie, J. Y. G., & Zhang, Y. (2020) · Microorganisms · doi:10.3390/microorganisms8071067 · Cited by 59
Genetic influences on viral-induced cytokine responses in the lung
Forbester, J. L., & Humphreys, I. R. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00355-6 · Cited by 56
Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan
Choi, Y., Kim, H. J., Park, J., Lee, M., Kim, S. Y., Koyanagi, A., Smith, L., Kim, M. S., Rahmati, M., Lee, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48825-w · Cited by 60
Pediatric SARS, H1N1, MERS, EVALI, and Now Coronavirus Disease (COVID-19) Pneumonia: What Radiologists Need to Know
Foust, A. M., Winant, A. J., Chu, C. W., Das, K. M., Phillips, G. S., & Lee, E. Y. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.23267 · Cited by 54
Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis
Arranz-Herrero, J., Presa, J., Rius‐Rocabert, S., Utrero‐Rico, A., Arranz-Arija, J. Á., Lalueza, A., Escribese, M. M., Ochando, J., Soriano, V., & Nistal‐Villán, E. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.04.003 · Cited by 51
El suplemento con altas dosis de vitamina D podría representar una alternativa promisoria para prevenir o tratar la infección por COVID-19
Mansur, J. L., Tajer, C. D., Mariani, J. A., Inserra, F., Ferder, L., & Manucha, W. A. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.05.003 · Cited by 51
Peripheral blood inflammatory markers in predicting prognosis in patients with COVID‐19. Some differences with influenza A
Zhao, Y., Yu, C., Ni, W., Shen, H., Qiu, M., & Zhao, Y. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23657 · Cited by 46
Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID‐19 in the US
Friedman, A. N., Guirguis, J. K., Kapoor, R., Gupta, S., Leaf, D. E., Timsina, L., & for the STOP‐COVID Investigators (2021) · Obesity · doi:10.1002/oby.23245 · Cited by 45
Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy
Gao, N., & Rezaee, F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122619 · Cited by 47
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Serrano, G. E., Walker, J. E., Tremblay, C., Piras, I. S., Huentelman, M. J., Belden, C. M., Goldfarb, D., Shprecher, D., Atri, A., Adler, C. H., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac056 · Cited by 45
Influenza Myopericarditis and Pericarditis: A Literature Review
Radovanovic, M., Petrović, M., Barsoum, M. K., Nordstrom, C. W., Calvin, A. D., Dumic, I., Jevtic, D., & Hanna, R. D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144123 · Cited by 45
Clinical characteristics of COVID-19 and its comparison with influenza pneumonia
Qu, J.-J., Chang, L. K., Tang, X., Du, Y., Yang, X., Liu, X., Han, P., & Xue, Y. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1798668 · Cited by 44
Macrophages: First guards in the prevention of cardiovascular diseases
Nasser, M. I., Zhu, S., Huang, H., Zhao, M., Wang, B., Huang, P. C., Geng, Q., & Zhu, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117559 · Cited by 45
Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection
Mansur, J. L., Tajer, C. D., Mariani, J. A., Inserra, F., Ferder, L., & Manucha, W. A. (2020) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2020.11.003 · Cited by 45
Beyond energy balance regulation: The underestimated role of adipose tissues in host defense against pathogens
Barthelemy, J., Bogard, G., & Wolowczuk, I. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1083191 · Cited by 46
Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
Conte, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137135 · Cited by 42
Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammation
Speaks, S., McFadden, M. I., Zani, A., Solstad, A., Leumi, S., Roettger, J. E., Kenney, A. D., Bone, H., Zhang, L., Denz, P. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47067-0 · Cited by 44
Epidemiological characteristics of respiratory viruses in patients with acute respiratory infections during 2009–2018 in southern China
Huang, X., Yuan, L., Ye, C., Zhu, X., Lin, C., Zhang, D., He, K.-S., Niu, R.-X., Cao, K., & Xu, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.051 · Cited by 39
Therapeutic potentials of ononin with mechanistic insights: A comprehensive review
Bhuia, M. S., Aktar, A., Chowdhury, R., Ferdous, J., Rahman, M. A., Hasan, M. S. A., & Islam, M. T. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103302 · Cited by 39
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations
Xu, J.-Q., Zhang, W.-Y., Fu, J.-J., Fang, X.-Z., Gao, C.-G., Li, C., Yao, L., Li, Q.-L., Yang, X.-B., Ren, L.-H., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00581-0 · Cited by 37
Influenza vaccine uptake among at-risk adults (aged 16–64 years) in the UK: a retrospective database analysis
Oakley, S., Bouchet, J., Costello, P., & PARKER, J. E. (2021) · BMC Public Health · doi:10.1186/s12889-021-11736-2 · Cited by 37
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy
Chen, Z., Behrendt, R., Wild, L., Schlee, M., & Bode, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02174-2 · Cited by 44
IFN-γ Drives TNF-α Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Staphylococcus aureus Pneumonia
Verma, A. K., Bauer, C. D., Palani, S., Metzger, D. W., & Sun, K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100328 · Cited by 36
Moslea Herba flavonoids alleviated influenza A virus-induced pulmonary endothelial barrier disruption via suppressing NOX4/NF-κB/MLCK pathway
Yu, W.-Y., Li, L., Wu, F., Zhang, H., Fang, J., Zhong, Y.-S., & Yu, C.-H. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112641 · Cited by 35
Comparison between Patients Hospitalized with Influenza and COVID-19 at a Tertiary Care Center
Donnino, M. W., Moskowitz, A. L., Thompson, G. S., Heydrick, S. J., Pawar, R., Berg, K. M., Mehta, S. M., Patel, P. V., & Grossestreuer, A. V. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06647-2 · Cited by 34
Silencing of lncRNA MIAT alleviates LPS-induced pneumonia via regulating miR-147a/NKAP/NF-κB axis
Liu, M., Li, W., Song, F., Zhang, L., & Sun, X. (2020) · Aging · doi:10.18632/aging.202284 · Cited by 34
Update in Viral Infections in the Intensive Care Unit
Fragkou, P. C., Moschopoulos, C. D., Karofylakis, E., Kelesidis, T., & Tsiodras, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.575580 · Cited by 33
The Role of Gut Microbiota in the Modulation of Pulmonary Immune Response to Viral Infection Through the Gut-Lung Axis
Chen, N., Li, L., Han, Y., & Chen, Z. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s525880 · Cited by 41
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
Faist, A., Janowski, J., Kumar, S., Hinse, S., Çalışkan, D. M., Lange, J., Ludwig, S., & Brunotte, L. (2022) · Cells · doi:10.3390/cells11142198 · Cited by 31
Isofraxidin ameliorated influenza viral inflammation in rodents via inhibiting platelet aggregation
Jin, L., Ying, Z.-H., Yu, C.-H., Zhang, H., Yu, W.-Y., & Wu, X.-N. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106521 · Cited by 32
Nanoparticles and Antiviral Vaccines
Liu, S., Hu, M., Liu, X., Liu, X., Chen, T., Zhu, Y., Liang, T., Xiao, S., Li, P., & Ma, X. (2023) · Vaccines · doi:10.3390/vaccines12010030 · Cited by 35
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2019
Tenforde, M. W., Noah, K. P., O’Halloran, A. C., Kirley, P. D., Hoover, C., Alden, N. B., Armistead, I., Meek, J. I., Yousey-Hindes, K. M., Openo, K. P., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae427 · Cited by 31
COVID-19 associated complications and potential therapeutic targets
Monpara, J. D., Sodha, S., & Gupta, P. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173548 · Cited by 32
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
Yang, F., Yue, R., Luo, X., Liu, R., & Huang, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.543718 · Cited by 31
RUNX1 inhibits the antiviral immune response against influenza A virus through attenuating type I interferon signaling
Hu, Y., Pan, Q., Zhou, K., Ling, Y., Wang, H., & Li, Y. (2022) · Virology Journal · doi:10.1186/s12985-022-01764-8 · Cited by 31
NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
Bjorgen, J. C., Dick, J. K., Cromarty, R. T., Hart, G. T., & Rhein, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267774 · Cited by 30
Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations
Wang, Y.-H., Limaye, A., Liu, J., & Wu, T.-N. (2022) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2022.08.004 · Cited by 30
Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective
Chan, Y., Ng, S. W., Singh, S. K., Gulati, M., Gupta, G., Chaudhary, S. K., Hing, G. B., Collet, T., MacLoughlin, R. J., Löbenberg, R., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119744 · Cited by 27
Qingjin Huatan decoction protects mice against influenza a virus pneumonia via the chemokine signaling pathways
Liu, M., Zhao, F., Xu, J., Zhu, X., Zhao, Y., Wen, R., Anirudhan, V., Rong, L., Tian, J., & Cui, Q. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116745 · Cited by 28
The role of programmed cell death in organ dysfunction induced by opportunistic pathogens
Yangyanqiu, W., Weng, L., Wu, X., & Du, B. (2025) · Critical Care · doi:10.1186/s13054-025-05278-x · Cited by 30
Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis
Seeherman, S., & Suzuki, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041659 · Cited by 27
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages
Ferreira, A. C., Sacramento, C. Q., Pereira-Dutra, F. S., Rodrigues, N. F., Silva, P. P., Mattos, M., de Freitas, C. S., Marttorelli, A., de Melo, G. R., Campos, M. M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1067285 · Cited by 32
Clinical outcomes and economic burden of seasonal influenza and other respiratory virus infections in hospitalized adults
Bölek, H., Özışık, L., Çalışkan, Z., & Tanrıöver, M. D. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28153 · Cited by 26
Journey of monocytes and macrophages upon influenza A virus infection
Ruscitti, C., Radermecker, C., & Marichal, T. (2024) · Current Opinion in Virology · doi:10.1016/j.coviro.2024.101409 · Cited by 27
Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19?
Gvozdjáková, A., Klauco, F., Kucharská, J., & Sumbalová, Z. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_126 · Cited by 26
Clinical features and risk factors for severe influenza in children: A study from multiple hospitals in Shanghai
Shi, Y., Chen, W., Zeng, M., Shen, G., Sun, C., Liu, G., Gong, H., Wang, C., Ge, M., Xu, J., et al. (2021) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2021.05.002 · Cited by 26
Neurotrophin Signaling Impairment by Viral Infections in the Central Nervous System
Böhmwald, K., Andrade, C. A., Mora, V. P., Muñóz, J. T., Ramírez, R. A., Rojas, M. F., & Kalergis, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105817 · Cited by 27
Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo
Lee, D., Jo, H., Jang, Y., Bae, S., Agura, T., Kang, D., Kang, M., Kim, Y., Cho, N., Kim, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010678 · Cited by 27
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case–Control Study
Russo, A., Pisaturo, M., Zollo, V., Martini, S., Maggi, P., Numis, F. G., Gentile, I., Sangiovanni, N., Rossomando, A. M., Bianco, V., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124055 · Cited by 26
Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus
Guan, W., Qu, R., Shen, L., Mai, K., Pan, W., Lin, Z., Chen, L., Dong, J., Zhang, J., Feng, P., et al. (2023) · Med · doi:10.1016/j.medj.2023.11.001 · Cited by 26
Impact of influenza infection on the short- and long-term health of patients with chronic obstructive pulmonary disease
Wallick, C. J., To, T. M., Korom, S., Masters, H., Hanania, N. A., & Moawad, D. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2098630 · Cited by 26
High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseases
Jia, X., Crawford, J. C., Gebregzabher, D., Monson, E. A., Mettelman, R. C., Wan, Y., Ren, Y., Chou, J. S., Novak, T., McQuilten, H. A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.026 · Cited by 25
Self-citation
Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease
Chakraborty, S., Cheng, B. Y.-L., Edwards, D. L., González, J. C., Chiu, D. K., Zheng, H., Scallan, C., Guo, X., Tan, G. S., Coffey, G., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.10.002 · Cited by 24
Pneumonia scoring systems for severe COVID-19: which one is better
Cheng, P., Wu, H., Yang, J., Song, X., Xu, M., Li, B., Zhang, J., Qin, M., Zhou, C., & Zhou, X. P. (2021) · Virology Journal · doi:10.1186/s12985-021-01502-6 · Cited by 25
Carbonized Nanogels Derived from Quercetin as a Potential Antiviral and Anti-Inflammatory Agent Against Influenza A Virus
Lin, H., Zeng, Y.-T., Lin, C., Harroun, S. G., Anand, A., Chang, L., Wu, C., Lin, H. ‐., & Huang, C. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.04.124 · Cited by 27
1H NMR-Based Biochemometric Analysis of Morus alba Extracts toward a Multipotent Herbal Anti-Infective
Langeder, J., Döring, K., Schmietendorf, H., Grienke, U., Schmidtke, M., & Rollinger, J. M. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.2c00481 · Cited by 25
The chemokine receptor CXCR3 promotes CD8 + T cell–dependent lung pathology during influenza pathogenesis
Guo, K., Yombo, D. J. K., Wang, Z., Navaeiseddighi, Z., Xu, J., Schmit, T., Ahamad, N., Tripathi, J. K., Kumar, B. D., Mathur, R., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj1120 · Cited by 25
Contribution of Pro-Inflammatory Molecules Induced by Respiratory Virus Infections to Neurological Disorders
Böhmwald, K., Andrade, C. A., & Kalergis, A. M. (2021) · Pharmaceuticals · doi:10.3390/ph14040340 · Cited by 28
Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice
Song, J., Zhao, J., Cai, X., Qin, S., Chen, Z., Huang, X., Li, R., Wang, Y., & Wang, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115653 · Cited by 22
The emerging role of NOTCH3 receptor signalling in human lung diseases
Bodas, M., Bharathiraja, S., Karmouty‐Quintana, H., Vitiello, P. F., & Walters, M. S. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.27 · Cited by 24
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia
Lee, C. H., Banoei, M. M., Ansari, M., Cheng, M. P., Lamontagne, F., Griesdale, D., Lasry, D. E., Demir, K. K., Dhingra, V. K., Tran, K. C., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04843-0 · Cited by 28
Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults
Rosero, C., Gravenstein, S., & Saade, E. (2025) · Drugs & Aging · doi:10.1007/s40266-024-01169-y · Cited by 26
Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19
McCartney, S. A., Kachikis, A. B., Huebner, E. M., Walker, C. L., Chandrasekaran, S., & Waldorf, K. M. A. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13320 · Cited by 25
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)
Bersanelli, M., Giannarelli, D., Giorgi, U. D., Pignata, S., Maïo, M. D., Clemente, A., Verzoni, E., Giusti, R., Napoli, M. D., Aprile, G., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002619 · Cited by 23
Reduced platelet mitochondrial respiration and oxidative phosphorylation in patients with post COVID-19 syndrome are regenerated after spa rehabilitation and targeted ubiquinol therapy
Sumbalová, Z., Kucharská, J., Rausová, Z., Palacka, P., Kovalčíková, E., Takácsová, T., Mojto, V., Navas, P., López‐Lluch, G., & Gvozdjáková, A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1016352 · Cited by 23
Pharmacoinformatics and Breed-Based De Novo Hybridization Studies to Develop New Neuraminidase Inhibitors as Potential Anti-Influenza Agents
Bourougaa, L., Ouassaf, M., Alhatlani, B. Y., Abdallah, E. M., & Kawsar, S. M. A. (2023) · Molecules · doi:10.3390/molecules28186678 · Cited by 23
Indoleamine 2,3-dioxygenase 1 drives epithelial cells ferroptosis in influenza-induced acute lung injury
Zheng, Y., Zhang, Y., Chen, Y., Deng, X., Liu, B., Xu, Q., Qian, C., Zhang, Z., Wang, K., Zeng, Y., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103572 · Cited by 23
Innate immune role of IL-6 in influenza a virus pathogenesis
Li, X., Huang, C., Rai, K. R., & Xu, Q. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1605446 · Cited by 26

Authors: Kalil, A. C., & Thomas, P. G.
Affiliations: St. Jude Children's Research Hospital (US)
ORCID: Kalil, Andre C.
Thomas, Paul G.
Venue: Critical Care
Publisher: Springer Science and Business Media LLC
Published: 2019-07-19
Volume: 23
Issue: 1
Pages: 258-258
ISSN: 1364-8535 (ISSN-L)
DOI: 10.1186/s13054-019-2539-x
PMC: PMC6642581
OpenAlex: W2963276598
Cited by: 524
References: 89
Citations by year: 2026: 60 · 2025: 61 · 2024: 95 · 2023: 91 · 2022: 75 · 2021: 74 · 2020: 62 · 2019: 5
FWCI: 7.88
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Critical Care (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: influenza virus, critical illness, acute respiratory distress syndrome, influenza-associated pneumonia, bacterial co-infection, sepsis, hemagglutinin cleavage, extracellular matrix degradation, H3N2, intensive care unit admission, risk factors, influenza vaccination, influenza epidemiology
MeSH terms: Adult, Female, Humans, Influenza, Human, Influenza Vaccines, Middle Aged, Obesity, Orthomyxoviridae, Respiratory Distress Syndrome, Sex Factors, Critical Illness, Sepsis, Protective Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Influenza virus-related critical illness: pathophysiology and epidemiology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks